Tosiban 37.5mg Injection
Marketer
Zuventus Healthcare Ltd
Salt Composition
Atosiban (37.5mg)
Overview Tosiban 37.5mg Injection
To treat preterm labor—uterine contractions commencing prematurely—Tosiban 37.5mg Injection reduces the intensity of these contractions, thereby delaying childbirth. Administered intravenously by a healthcare professional in a medical facility, self-injection is strictly prohibited. Dosage and frequency are determined individually by your physician based on your condition's severity. Treatment is limited to a maximum of three administrations; exceeding this is inadvisable. Common adverse effects include injection site irritation, headache, nausea, vomiting, hyperglycemia, and hypotension (potentially causing dizziness). Report any concerning or persistent side effects to your doctor; management strategies may be available. To mitigate dizziness, rise slowly from a seated or recumbent position. Prior to treatment, disclose any history of kidney or liver impairment, pregnancies exceeding 24 weeks, or multiple gestations. Inform your doctor of all other medications you are using, as interactions can affect Tosiban's efficacy or mechanism. Your doctor will monitor uterine contractions and fetal heart rate throughout the treatment period.
Uses of Tosiban 37.5mg Injection
Early onset of labor
Major Benefits of Tosiban 37.5mg Injection:
This medication will be administered by your healthcare provider; please do not self-medicate.
Common Side effects of Tosiban 37.5mg Injection:
- Injection site reaction
- Headache
- Nausea
- Increased glucose level in blood
- Decreased blood pressure
- Dizziness
- Hot flashes
- Slow heart rate
- Vomiting
How to use Tosiban 37.5mg Injection:
Administering this medication will be handled by your physician or their nursing staff; self-medication is strictly prohibited.
How Tosiban 37.5mg Injection works:
Tosiban 37.5mg Injection functions by inhibiting oxytocin, a naturally occurring hormone that stimulates uterine contractions. This inhibition helps postpone preterm labor.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption alongside Tosiban 37.5mg Injection is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Tosiban 37.5mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in extreme circumstances where a physician deems the potential benefits outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Tosiban 37.5mg Injection to breastfeeding individuals is contraindicated due to potential infant toxicity. Evidence indicates the drug may harm the nursing infant.
DrivingSAFE
The administration of a 37.5mg Tosiban injection typically has no impact on driving capabilities.
KidneySAFE IF PRESCRIBED
Tosiban 37.5mg Injection appears to pose minimal risk for individuals with impaired kidney function. Preliminary findings indicate that dose modification of Tosiban 37.5mg Injection might be unnecessary in this population. Physician consultation is recommended.
LiverCAUTION
Individuals with hepatic impairment should use Tosiban 37.5mg Injection cautiously. Dosage modification may be necessary for these patients. Physician consultation is advised.
What if you forget to take Tosiban 37.5mg Injection :
NA
Facts to Know About Tosiban 37.5mg Injection
| Label | Value |
|---|---|
| Chemical Category | Short peptide |
| Developing Habits | No. |
| Type of Therapy | Obstetrics and Gynecology |
| Behavioral Class | Oxytocin Receptor Blocker |





